// App-Quantinova.ai

: ESTIMATION OF NHS SAVINGS THROUGH THE INTRODUCTION OF REAL-TIME CONTINUOUS GLUCOSE MONITORING FOR PREGNANT WOMEN WITH TYPE 1 DIABETES

Researchers

Presenter

  • Murphy H

Principal Investigators

  • Feig D

  • Sanchez J

  • De Portu S

  • Sale A

Medical Centers

  • Medtronic, Health Economics, London, United Kingdom

  • Medicine, University of East Anglia, Norwich Medical School, Norwich, United Kingdom

  • Lunenfeld- Tanenbaum Research Institute and University of Toronto, Medicine, Toronto, Canada

  • Medtronic, Market Access, Tolochenza, Switzerland

  • Sunnybrook Research Institute, Medicine, Toronto- Ontario, Canada

Locations

  • United Kingdom

  • Canada

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 1 diabetes mellitus

  • Preeclampsia

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved